Praxis Precision Medicines, Inc. Cash Flow Statement

Cash Flow Statement Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -35.51M-61.82M-167.06M-214.99M-126.37M-200.16M
Depreciation and Depletion 0.04M0.05M0.20M0.42M0.43M0.40M
Share-based Compensation 0.67M5.21M22.69M28.59M24.86M41.36M
Gains from Investment Securities 2.09M4.07M0.26M0.14M0.31M
Cash from Operations -33.42M-52.62M-124.55M-185.04M-111.14M-131.76M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.64M0.70M-2.09M-1.00M0.84M5.01M
Depreciation & Amortization (CF) 0.04M0.05M0.20M0.42M0.43M0.40M
Change in Working Capital
Change in Account Payables -0.84M0.96M7.27M3.89M-8.86M6.71M
Change in Accured Expenses 1.74M7.41M15.45M-10.46M-8.50M16.11M
Investing Activities
Capital Expenditures 0.10M0.00M1.05M0.44M0.05M
Change in Acquisitions & Divestments 24.70M180.35M39.00M123.03M
Cash from Investing Activities -0.10M-140.52M96.89M38.95M-248.49M
Financing Activities
Other financing activities 0.57M0.26M
Change in Capital Stock
Shares Issued 200.89M98.41M1.43M0.42M2.63M
Preferred Shares Issued 60.39M133.44M
Misc.
Cash from Financing Activities 60.39M304.42M107.59M10.46M91.87M514.32M
Change in Cash 26.86M251.79M-157.49M-77.69M19.68M134.07M
Free Cash Flow -33.52M-52.63M-125.60M-185.49M-111.19M-131.76M
Net Cash Flow 26.86M251.79M-157.49M-77.69M19.68M134.07M